Skip to main content

Table 3 Demographics and outcomes of patients who received HFNO/CPAP, categorised by those who were initially treated with the LeVe CPAP Systems and those who were treated with a non-LeVe CPAP Systems

From: Descriptive account of the first use of the LeVe CPAP System, a new frugal CPAP System, in adult patients with COVID-19 Pneumonitis in Uganda

 

Initial treatment with LeVe CPAP System

Initial treatment with non-LeVe CPAP System

Total

Number

28

15

Sex

Male

11 (39%)

7 (47%)

Female

17 (61%)

8 (53%)

Age

Range

28–91

45–77

Median

55

57

Duration on CPAP

Range

1–18

1–9

Mean

7

6

Median

8

5

Outcome

Died

14 (50%)

7 (47%)

Discharged

11 (40%)

8 (53%)

Referred

3 (10%)

0 (0%)